FLG client Axcient, Inc., announced today that they raised a $15.5 million Series C round from Scale Venture Partners; Rory O’Driscoll will join the board of directors. Company press release. FLG partner: John Finegan.
October 3, 2011
SEATTLE-November 16, 2022 -(BUSINESS WIRE)–Curevo Vaccine (Curevo), a privately held clinical-stage biotechnology company dedicated to reducing the burden of infectious disease by developing safe and highly-effective vaccines, today announced the closing of a $26 million Series A1 financing round. This brings total funding raised in 2022 to $86M for the…Read More
“Taking over management of Adaptive Path, I needed an experienced partner who advocated for the health of the business and could be a counselor on big decisions. From turnaround of the business through to our acquisition by Capital One, Skip Smith from FLG Partners was that and much more. His work began with focusing us on building back a healthy business step-by-step, improving the accounting and analysis to make sure we made every project and every month, a profitable one. His role matured to shaping our recapitalization and mentoring me and other top managers in the organization as we ran and grew the business. Skip also made key introductions that supported our acquisition process. Throughout it all, I trusted Skip for his straight read on situations, tough advice that I needed to hear, but also for his love of our business and his passion to see it succeed with the leadership of myself and my team. Skip was central to our success.”Brandon Schauer, Head of Emerging Design Practices, Capital One